good set of number management is very bullish for future growth. yesterday concall was worth listening.
management is experting improvement in ebidta margin from net quater.
growth in CDMO is quite good. i am holding it for 2-3 year till then their new capacity are live and running.
moving in a right direction. debt reduction is going on and management is moving the business in right direction.
tailwind continued, overall sector is posting good numbers.
dis: invested
(i am holding these stocks, please share your thought)
Really liking how your portfolio companies are all firing at the same time when it comes to earnings. What are your exit criteria for portfolio companies?
1 Like
I use both technical and fundamental while entry and exit. When I find my holding are in good momentum and their value is not very on extreme i just hold on it.if valuation is not reasonable it start trimming it but slow until momentum is their. On portfolio level I need both fundamental and technical with valuation on my side. But in the end market is supreme.
| S.NO | STOCK | REVENUE GROWTH | EPS GROWTH |
|---|---|---|---|
| 1 | GARWARE HI TECH | 56% | 127% |
| 2 | KRSNAA | 22% | 89% |
| 3 | NUVAMA | 43% | 74% |
| 4 | SENCO | 27% | 40% |
| 5 | SUPRIYA LIFE SCIENCE | 19% | 93% |
| 6 | ORIENTAL A | 4% | 555% |
| 7 | LAURAS LAB | 0% | -46% |
| 8 | NEULAND LABS | -26% | -63% |
| 9 | THYROCARE TECH | 20% | 46% |
| 10 | PRIVI SPECILITY | 17% | 46% |
| 11 | DEEPAK FERTILIZER | 13% | 250% |
| 12 | JUBLANT PHARMOVA | 4% | 65% |
| 13 | Edelweiss Financial Services | 31% | 44% |
| AVERAGE | 18% | 102% |
On portfolio level earnings are quite good, currently portfolio is 5.5% down it is performing well against nifty ,where nifty is 10% down.
| COMPANY | PERCENTAGE |
|---|---|
| AWFIS | 4.1 |
| DEEPAK FERTILIZER | 7.1 |
| EDELWEISS | 4.8 |
| GARWARE HI TECH | 16.3 |
| JUBILANT PHARMOVA | 7.1 |
| KRSNAA | 5.9 |
| LAURAS LAB | 4.6 |
| NUVAMA | 10.8 |
| ORIENTAL AROMATIC | 3.6 |
| PRIVI | 6.5 |
| SENCO | 10.7 |
| SOLARA | 4.1 |
| SUPRIYA | 8.9 |
| THYROCARE | 5.6 |
| TOTAL | 100 |
Recently make some changes sold Neuland to buy Solara and add Awfis ,
Solara- It look likes management is moving in a right direction due to past performance valuation is also cheap.
Neuland - sold due to valuation getting better opportunity.
Awfis - expecting good growth, cash flow are good and enough for future growth.2-3 years are looking good for the company.
4 Likes
Do look at Pn gadgil, i had almost similar allocation to Senco but to me it seems like Png with such high growth looks reasonably valued & incremental chnage is much more in Png .Now with the entry of Png Rerating of Senco looks difficult at parlance with their growth.
1 Like